- Investopedia•2 days ago
A look at Tesaro's recent decline and the bearish head and shoulders pattern emerging in its chart.
- TheStreet.com•2 days ago
New drug launches and late stage trials will be under the microscope as eight European pharmaceuticals companies report Q1 earnings starting next week.
- Motley Fool•3 days ago
The drugmaker reported that veliparib failed to outperform standard treatment in breast cancer and non-small-cell lung cancer trials.
AZN : Summary for Astrazeneca PLC - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||29.63 - 29.85|
|52 Week Range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.57|
|Dividend & Yield||1.90 (6.30%)|
|1y Target Est||N/A|